Literature DB >> 25933970

Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain.

Andrzej Moniczewski1, Maciej Gawlik1, Irena Smaga1, Ewa Niedzielska1, Jan Krzek2, Edmund Przegaliński3, Joanna Pera4, Małgorzata Filip5.   

Abstract

Oxidative stress is a dysfunctional state of living cells, caused by the disturbance of the pro-/antioxidative equilibrium. This dynamic equilibrium, constitutive for all aerobic organisms, is an inevitable necessity of maintaining the level of oxidative factors on non-destructive value to the cell. Among these factors reactive oxygen species (ROS) and reactive nitrogen species (RNS) are the best known molecules. This review article shows the current state of knowledge on the chemical specificity, relative reactivity and main sources of ROS and RNS in biological systems. As a Part 1 to the report about the role of oxidative stress in psychiatric disorders (see Smaga et al., Pharmacological Reports, this issue), special emphasis is placed on biochemical determinants in nervous tissue, which predisposed it to oxidative damage. Oxidative stress can be identified based on the analysis of various biochemical indicators showing the status of antioxidant barrier or size of the damage. In our article, we have compiled the most commonly used biomarkers of oxidative stress described in the literature with special regard to potentially effective in the early diagnosis of neurodegenerative processes.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Antioxidants; Antioxidative barrier; Biomarkers; Oxidative stress; Reactive species

Mesh:

Substances:

Year:  2015        PMID: 25933970     DOI: 10.1016/j.pharep.2014.12.014

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  12 in total

1.  Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression.

Authors:  Suene Vanessa da Silva Souza; Priscila Batista da Rosa; Vivian Binder Neis; Júlia Dubois Moreira; Ana Lúcia S Rodrigues; Morgana Moretti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-28       Impact factor: 3.000

Review 2.  Oxidative/Nitroxidative Stress and Multiple Sclerosis.

Authors:  Tobore Onojighofia Tobore
Journal:  J Mol Neurosci       Date:  2020-08-07       Impact factor: 3.444

3.  Changes in the Brain Endocannabinoid System in Rat Models of Depression.

Authors:  Irena Smaga; Joanna Jastrzębska; Magdalena Zaniewska; Beata Bystrowska; Dawid Gawliński; Agata Faron-Górecka; Żaneta Broniowska; Joanna Miszkiel; Małgorzata Filip
Journal:  Neurotox Res       Date:  2017-02-28       Impact factor: 3.911

Review 4.  Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.

Authors:  Joel R Frandsen; Prabagaran Narayanasamy
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

5.  Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone.

Authors:  Andrea C Rossetti; Maria Serena Paladini; Martina Colombo; Piotr Gruca; Magdalena Lason-Tyburkiewicz; Katarzyna Tota-Glowczyk; Mariusz Papp; Marco A Riva; Raffaella Molteni
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

Review 6.  Major Depression: One Brain, One Disease, One Set of Intertwined Processes.

Authors:  Elena V Filatova; Maria I Shadrina; Petr A Slominsky
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

Review 7.  Evaluating the Oxidative Stress in Inflammation: Role of Melatonin.

Authors:  Aroha Sánchez; Ana Cristina Calpena; Beatriz Clares
Journal:  Int J Mol Sci       Date:  2015-07-27       Impact factor: 5.923

8.  The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates.

Authors:  Ather Muneer; Rana Mazommil
Journal:  Psychiatry Investig       Date:  2018-08-20       Impact factor: 2.505

9.  The Microbiota-Gut-Brain Axis Heart Shunt Part I: The French Paradox, Heart Disease and the Microbiota.

Authors:  Mark Obrenovich; Bushra Siddiqui; Benjamin McCloskey; V Prakash Reddy
Journal:  Microorganisms       Date:  2020-03-30

10.  Peripheral non-enzymatic antioxidants in patients with schizophrenia: a case-control study.

Authors:  Zhe Lu; Tianyang Wen; Yingtan Wang; Weijing Kan; Guanglei Xun
Journal:  BMC Psychiatry       Date:  2020-05-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.